Category: News

We are excited to announce a significant update to the pricing strategy for our clinical trial services. In response to feedback from our valued clients and industry stakeholders, Anatomise Biostats is introducing a modular pricing strategy. This new approach replaces our previous hourly, retainer, and project-based pricing models to offer greater transparency, efficiency, and value to our clients in the medtech, medical device, and pharmaceutical sectors.

What’s New?

Starting immediately, the modular pricing strategy will apply to all new clinical trial projects, with the following key features:

• Base Package: A minimum commitment of £200,000 per annum, billed in six-monthly instalments. This base package covers core services, including biostatistics, quality control, and standard programming.
• Add-On Services: For clients requiring additional expertise, we offer services such as bioinformatics or data science for an additional £50,000 per annum.
• Multiple Concurrent Trials: If your project involves multiple concurrent clinical trials, an additional fee of £50,000 will apply for statistical programming to account for the complexity and scope of the work.

Why Are We Making These Changes?

At Anatomise Biostats, we strive to provide services that are not only robust and reliable but also tailored to the evolving needs of our clients. After careful consideration and extensive consultation with industry stakeholders, we have implemented these changes for the following reasons:

1. Responding to Industry Feedback
   Our clients have consistently voiced the need for greater predictability and clarity in pricing. The modular strategy directly addresses these concerns by offering a clear, upfront pricing model.
2. Simplifying the Bidding Process
   Typically, when engaging with a new vendor, clinical teams spend a lot of time in preliminary discussions trying to assess resource allocation and overall costs before any agreements are made. This can be time-consuming and uncertain. With our new pricing model, you’ll have a clear idea of costs before those initial discussions even begin, saving both time and resources.
   By presenting upfront pricing, we streamline the proposal process, enabling these discussions to be more productive and focused. There’s no need for lengthy back-and-forth before signing an NDA, and you can move faster towards getting a project underway.
3. Standardising Pricing for Consistency
   In an industry where every project is unique, maintaining consistency in pricing can be a challenge. Our modular pricing strategy simplifies this by providing standardised rates that apply across various types of projects, making financial planning and forecasting much easier.
4. Efficiency in Onboarding and Project Execution
   One of the key inefficiencies in traditional pricing models is the extensive time and money spent on human resources, onboarding, and integrating consultants. We have calculated that millions are wasted annually on these activities, which detract from the primary goal: delivering high-quality clinical trial results.
   With our modular approach, we eliminate the need for interviewing, background checks, and hours spent on induction SOPs, which are typical in Functional Service Provider (FSP) models. This allows us—and you—to focus on what truly matters: the success of your clinical trial.

Additional Benefits of the Modular Pricing Model

5. Improved Budget Control and Forecasting
   The modular pricing model provides a clear understanding of costs upfront, allowing for better budget control and financial forecasting. This transparency helps avoid unexpected expenses later in the project, enabling you to allocate resources more effectively throughout the clinical trial lifecycle.
6. Flexibility and Scalability
   Our modular approach offers flexibility, enabling clients to add or remove services as their project evolves. As your clinical trial progresses, you can easily scale up services such as bioinformatics or statistical programming as needed, without disrupting the workflow.
7. Optimised Resource Allocation
   By knowing upfront what services are included and at what cost, your clinical teams can more efficiently allocate internal resources. This ensures that your in-house team remains focused on core project tasks, while specialised work is seamlessly managed by Anatomise Biostats.
8. Reduced Administrative Burden
   With a clear pricing structure in place, there’s no need for protracted negotiations or multiple rounds of contract discussions. This reduces the administrative burden for both sides, allowing your team to concentrate on project execution rather than managing unnecessary paperwork or HR processes.
9. Shorter Time to Project Start
   Our upfront, standardised pricing model allows projects to commence more quickly by eliminating the delays associated with cost discussions and vendor evaluations. This means faster project initiation, helping you meet critical timelines more efficiently.
10. Clearer Accountability and Deliverables
    With defined packages and associated costs, there is greater clarity around deliverables. Both parties have a mutual understanding of what will be delivered and when, ensuring stronger project management and accountability throughout the process.

Our Commitment to Streamlining Your Experience

At the heart of this new pricing model is our commitment to making the clinical trial process more efficient, predictable, and ultimately profitable for our clients. By minimising unnecessary HR expenses, simplifying the proposal process, and removing bottlenecks in onboarding, we aim to streamline the experience of working with us.

Our ultimate goal is to make it easier and more straightforward for you to collaborate with us. With the modular pricing model, discussions with your clinical teams can focus on project strategy and deliverables, rather than getting bogged down in cost negotiations or time-consuming vendor assessments. This allows for faster decision-making and more effective project launches, helping you meet your timelines with greater confidence.

We understand that every clinical trial is a critical investment. Our goal is to support you with transparent, predictable pricing that allows you to focus on what matters most—moving your pipeline forward and achieving commercial success.

If you have any questions about this new pricing strategy or would like to discuss your upcoming project, please reach out to our team.

We look forward to helping you bring your innovations to market faster and more efficiently with Anatomise Biostats.